等离子电切术联合钬激光术治疗前列腺增生合并膀胱结石的效果分析

Analysis of the Effect of Plasma Resection Combined with Holmium Laser in the Treatment of Benign Prostatic Hyperplasia with Bladder Stones

目的探讨对前列腺增生伴有膀胱结石患者采用等离子电切术+钬激光术完成治疗后获得的临床效果。方法方便选取该院2017年6月—2020年5月收治的72例前列腺增生伴有膀胱结石患者,按照数字奇偶法分组;治疗组(36例):采用等离子电切术+钬激光术完成合并症治疗;参照组(36例):采用等离子电切术+开放取石术完成合并症治疗;就组间手术系列指标及随访指标进行对比。结果治疗组前列腺增生伴有膀胱结石患者术中失血量(65.21±17.69)mL少于参照组(97.75±14.61)mL,手术时间(73.83±22.45)min、置管时间(5.25±1.25)d、膀胱冲洗时间(42.29±11.05)h以及住院天数(6.99±2.25)d均短于参照组的(110.46±16.29)min、(9.96±2.81)d、(77.36±18.15)h以及(11.71±1.95)d,差异有统计学意义(t=8.509、7.923、9.188、9.902、9.511,P<0.05);治疗前,治疗组前列腺增生伴有膀胱结石患者RUV(132.61±42.89)mL、IPSS评分(25.39±4.42)分、Qmas(6.12±2.13)mL/s同参照组(131.09±39.96)mL、(25.46±4.33)分、(6.10±2.20)mL/s比较,差异无统计学意义(t=0.155、0.067、0.039,P>0.05);治疗后,治疗组前列腺增生伴有膀胱结石患者RUV(32.19±2.25)mL、IPSS评分(7.29±1.11)分均低于参照组(55.15±3.18)mL、(13.89±3.75)分,Qmas(19.16±4.59)mL/s高于参照组Qmas(16.05±5.19)mL/s,差异有统计学意义(t=35.363、10.125、2.693,P<0.05)。结论等离子电切术+钬激光术有效运用,可使前列腺增生伴有膀胱结石患者手术系列指标以及随访指标得到有效改善,最终实现前列腺增生伴有膀胱结石有效预后。

Objective To investigate the clinical results obtained after the treatment of benign prostatic hyperplasia accompanied by bladder stones by plasma resection+holmium laser.Methods 72 cases of prostate hyperplasia with bladder stones admitted to the hospital from June 2017 to May 2020 were conveniently selected and divided into groups according to the digital parity method;treatment group(36 cases):treated with plasma electrotomy+holmium laser to complete the treatment of comorbidities;reference group(36 cases):use plasma electrotomy+open lithotripsy to complete the treatment of comorbidities;compare the series of surgical indicators and follow-up indicators between the groups.Results In the treatment group,patients with prostate hyperplasia and bladder stones lost(65.21±17.69)mL less than the reference group(97.75±14.61)mL,operation time(73.83±22.45)min,catheterization time(5.25±1.25)d,bladder The washing time(42.29±11.05)h and the hospitalization days(6.99±2.25)d were shorter than the reference group's(110.46±16.29)min,(9.96±2.81)d,(77.36±18.15)h and(11.71±1.95)d,the difference was statistically significant(t=8.509,7.923,9.188,9.902,9.511,P<0.05);before treatment,in the treatment group,patients with prostate hyperplasia and bladder stones had RUV(132.61±42.89)mL,IPSS score(25.39±4.42)points,Qmas(6.12±2.13)mL/s and the reference group(131.09±39.96)mL,(25.46±4.33)points,(6.10±2.20)mL/s,there was no statistically significant difference(t=0.155,0.067,0.039,P>0.05);after treatment,the RUV(32.19±2.25)mL and IPSS score(7.29±1.11)points of patients with prostate hyperplasia and bladder stones in the treatment group were lower than those of the reference group(55.15±3.18)mL and(13.89±3.75)points,Qmas(19.16±4.59)mL/s was higher than Qmas(16.05±5.19)mL/s in the reference group,and the difference was statistically significant(t=35.363,10.125,2.693,P<0.05).Conclusion The effective use of plasma resection+holmium laser can effectively improve the series of surgical indicators and follow-up indicators for patients with benign prostatic hyperplasia and bladder stones,and finally achieve an effective prognosis for benign prostatic hyperplasia and bladder stones.